Bouys L, Chiodini I, Arlt W, Reincke M, Bertherat J (2021) Update on primary bilateral macronodular adrenal hyperplasia (PBMAH). Endocrine 71:595–603. https://doi.org/10.1007/s12020-021-02645-w
Article PubMed CAS Google Scholar
Cavalcante IP, Berthon A, Fragoso MC, Reincke M, Stratakis CA, Ragazzon B, Bertherat J (2022) Primary bilateral macronodular adrenal hyperplasia: definitely a genetic disease. Nat Rev Endocrinol 18:699–711. https://doi.org/10.1038/s41574-022-00718-y
Article PubMed CAS Google Scholar
Mete O, Erickson LA, Juhlin CC, Krijger RR, Sasano H, Volante M, Papotti MG (2022) Overview of the 2022 WHO Classification of Adrenal Cortical Tumors. Endocr Pathol 33:155–196. https://doi.org/10.1007/s12022-022-09710-8
Article PubMed PubMed Central CAS Google Scholar
Bertherat J, Bourdeau I, Bouys L, Chasseloup F, Kamenický P, Lacroix A (2023) Clinical, Pathophysiologic, Genetic, and Therapeutic Progress in Primary Bilateral Macronodular Adrenal Hyperplasia. Endocrine Reviews 44:567–628. https://doi.org/10.1210/endrev/bnac034
Violon F, Bouys L, Berthon A, Ragazzon B, Barat M, Perlemoine K, Guignat L, Terris B, Bertherat J, Sibony M (2023) Impact of Morphology in the Genotype and Phenotype Correlation of Bilateral Macronodular Adrenocortical Disease (BMAD): A Series of Clinicopathologically Well-Characterized 35 Cases. Endocr Pathol 34:179–199. https://doi.org/10.1007/s12022-023-09751-7
Article PubMed CAS Google Scholar
Chasseloup F, Bourdeau I, Tabarin A, et al (2021) Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing’s syndrome: a multicentre, retrospective, cohort study. The Lancet Diabetes & Endocrinology 9:813–824. https://doi.org/10.1016/S2213-8587(21)00236-9
Vaczlavik A, Bouys L, Violon F, et al (2022) KDM1A inactivation causes hereditary food-dependent Cushing syndrome. Genetics in Medicine 24:374–383. https://doi.org/10.1016/j.gim.2021
Article PubMed CAS Google Scholar
Violon F, Bouys L, Vaduva P, Chansavang A, Vaquier L, Letourneur F, Izac B, Giannone G, De Murat D, Gaillard M, Berthon A, Ragazzon B, Pasmant E, Sibony M, Bertherat J (2024) Somatic Molecular Heterogeneity in Bilateral Macronodular Adrenocortical Disease (BMAD) Differs Among the Pathological Subgroups. Endocr Pathol 35:194–206. https://doi.org/10.1007/s12022-024-09824-1
Article PubMed CAS Google Scholar
Correa R, Zilbermint M, Berthon A, Espiard S, Batsis M, Papadakis G, Xebouki P, Lodish M, Bertherat J, Faucz F, Stratakis C (2015) The ARMC5 gene shows extensive genetic variance in primary macronodular adrenocortical hyperplasia. European Journal of Endocrinology 173:435–440. https://doi.org/10.1530/EJE-15-0205
Article PubMed PubMed Central CAS Google Scholar
Jin P, Janjua MU, Zhang Q, Dong C, Yang Y, Mo Z (2018) Extensive ARMC5 genetic variance in primary bilateral macronodular adrenal hyperplasia that started with exophthalmos: a case report. J Med Case Reports 12:13. https://doi.org/10.1186/s13256-017-1529-3
Bouys L, Vaduva P, Jouinot A, et al (2025) KDM1A genetic alterations, a rare cause of primary bilateral macronodular adrenal hyperplasia, strongly associated with food-dependent Cushing’s syndrome: results of its systematic germline screening in 301 index cases and genotype/phenotype correlation. European Journal of Endocrinology 192:119–127. https://doi.org/10.1093/ejendo/lvaf016
Article PubMed CAS Google Scholar
Assié G, Libé R, Espiard S, et al (2013) ARMC5 Mutations in Macronodular Adrenal Hyperplasia with Cushing’s Syndrome. The New England Journal of Medicine 10. https://doi.org/10.1056/NEJMoa1304603
Sasano H, Suzuki T, Nagura H (1994) ACTH-independent macronodular adrenocortical hyperplasia: immunohistochemical and in situ hybridization studies of steroidogenic enzymes. Mod Pathol 7:215–219.
De Arruda Botelho MLA, Nishi MY, Ribeiro KB, Zerbini MCN (2023) Morphological Harbingers of ARMC5-Pathogenic Variant-Related Bilateral Macronodular Adrenocortical Disease. Endocr Pathol 34:200–212. https://doi.org/10.1007/s12022-023-09761-5
Article PubMed CAS Google Scholar
Swierczynska MM, Betz MJ, Colombi M, Dazert E, Jenö P, Moes S, Pfaff C, Glatz K, Reincke M, Beuschlein F, Donath MY, Hall MN (2019) Proteomic Landscape of Aldosterone-Producing Adenoma. Hypertension 73:469–480. https://doi.org/10.1161/HYPERTENSIONAHA.118.11733
Article PubMed CAS Google Scholar
Sohier P, Sanson R, Leduc M, Audebourg A, Broussard C, Salnot V, Just PA, Pasmant E, Mayeux P, Guillonneau F, Romagnolo B, Perret C, Terris B (2020) Proteome analysis of formalin-fixed paraffin‐embedded colorectal adenomas reveals the heterogeneous nature of traditional serrated adenomas compared to other colorectal adenomas. The Journal of Pathology 250:251–261. https://doi.org/10.1002/path.5366
Article PubMed CAS Google Scholar
Demichev V, Messner CB, Vernardis SI, Lilley KS, Ralser M (2020) DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat Methods 17:41–44. https://doi.org/10.1038/s41592-019-0638-x
Article PubMed CAS Google Scholar
Asleh K, Negri GL, Spencer Miko SE, Colborne S, Hughes CS, Wang XQ, Gao D, Gilks B, Chia S, Nielsen TO, Morin GB (2022) Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes. Nat Commun 13:896. https://doi.org/10.1038/s41467-022-28524-0
Article PubMed PubMed Central CAS Google Scholar
Lao L, Bourdeau I, Gagliardi L, He X, Shi W, Hao B, Tan M, Hu Y, Peng J, Coulombe B, Torpy DJ, Scott HS, Lacroix A, Luo H, Wu J (2022) ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. Nucleic Acids Research 50:6343–6367. https://doi.org/10.1093/nar/gkac483
Article PubMed PubMed Central CAS Google Scholar
Luo H, Lao L, Au KS, Northrup H, He X, Forget D, Gauthier MS, Coulombe B, Bourdeau I, Shi W, Gagliardi L, Fragoso M, Peng J, Wu J (2024) ARMC5 controls the degradation of most Pol II subunits, and ARMC5 mutation increases neural tube defect risks in mice and humans. Genome Biol 25:19. https://doi.org/10.1186/s13059-023-03147-w
Article PubMed PubMed Central CAS Google Scholar
Dürr UHN, Waskell L, Ramamoorthy A (2007) The cytochromes P450 and b5 and their reductases—Promising targets for structural studies by advanced solid-state NMR spectroscopy. Biochimica et Biophysica Acta (BBA) - Biomembranes 1768:3235–3259. https://doi.org/10.1016/j.bbamem.2007.08.007
Article PubMed CAS Google Scholar
Storbeck K-H, Swart AC, Fox CL, Swart P (2015) Cytochrome b5 modulates multiple reactions in steroidogenesis by diverse mechanisms. The Journal of Steroid Biochemistry and Molecular Biology 151:66–73. https://doi.org/10.1016/j.jsbmb.2014.11.024
Article PubMed CAS Google Scholar
Bhatt MR, Khatri Y, Rodgers RJ, Martin LL (2017) Role of cytochrome b5 in the modulation of the enzymatic activities of cytochrome P450 17α-hydroxylase/17,20-lyase (P450 17A1). The Journal of Steroid Biochemistry and Molecular Biology 170:2–18. https://doi.org/10.1016/j.jsbmb.2016.02.033
Article PubMed CAS Google Scholar
Okuno Y, Fukuhara A, Otsuki M, Shimomura I (2022) ARMC5-CUL3 E3 ligase targets full-length SREBF in adrenocortical tumors. JCI Insight 7:e151390. https://doi.org/10.1172/jci.insight.151390
Article PubMed PubMed Central Google Scholar
Uota A, Okuno Y, Fukuhara A, Sasaki S, Kobayashi S, Shimomura I (2024) ARMC5 selectively degrades SCAP-free SREBF1 and is essential for fatty acid desaturation in adipocytes. Journal of Biological Chemistry 300:107953. https://doi.org/10.1016/j.jbc.2024.107953
Article PubMed PubMed Central CAS Google Scholar
Espiard S, Drougat L, Libé R, et al (2015) ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences. The Journal of Clinical Endocrinology & Metabolism 100:E926–E935. https://doi.org/10.1210/jc.2014-4204
Cavalcante IP, Nishi M, Zerbini MCN, et al (2018) The role of ARMC5 in human cell cultures from nodules of primary macronodular adrenocortical hyperplasia (PMAH). Molecular and Cellular Endocrinology 460:36–46. https://doi.org/10.1210/jc.2014-4204
Comments (0)